Literature DB >> 9778217

The role of oncostatin M in animal and human connective tissue collagen turnover and its localization within the rheumatoid joint.

T E Cawston1, V A Curry, C A Summers, I M Clark, G P Riley, P F Life, J R Spaull, M B Goldring, P J Koshy, A D Rowan, W D Shingleton.   

Abstract

OBJECTIVE: To study the interaction of interleukin-1alpha (IL-1alpha) and oncostatin M (OSM) in promoting cartilage collagen destruction.
METHODS: Bovine, porcine, and human cartilage and human chondrocytes were studied in culture. The levels of collagenase (matrix metalloproteinase 1 [MMP-1]) and tissue inhibitor of metalloproteinases 1 (TIMP-1) were measured by bioassay and enzyme-linked immunosorbent assay (ELISA). The levels of OSM in rheumatoid synovial fluid were measured by ELISA.
RESULTS: When combined with OSM, IL-1alpha, IL-1beta, and tumor necrosis factor alpha released proteoglycan and collagen from cartilage. OSM was the only member of the IL-6 family to have this effect. Human tendon also responded to IL-1alpha and OSM. OSM increased the production of MMP-1 and TIMP-1 but when combined with IL-1alpha, synergistically promoted MMP-1 production in human chondrocytes and synovial fibroblasts. High levels of OSM were found in human rheumatoid synovial fluids, and confocal microscopy showed that OSM was produced by macrophages in rheumatoid synovial tissue.
CONCLUSION: These results highlight an important new mechanism by which there is irreversible loss of collagen from cartilage.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9778217     DOI: 10.1002/1529-0131(199810)41:10<1760::AID-ART8>3.0.CO;2-M

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  62 in total

1.  Murine oncostatin M stimulates mouse synovial fibroblasts in vitro and induces inflammation and destruction in mouse joints in vivo.

Authors:  C Langdon; C Kerr; M Hassen; T Hara; A L Arsenault; C D Richards
Journal:  Am J Pathol       Date:  2000-10       Impact factor: 4.307

2.  Osteoblasts and stromal cells isolated from femora in rheumatoid arthritis (RA) and osteoarthritis (OA) patients express IL-11, leukaemia inhibitory factor and oncostatin M.

Authors:  G Lisignoli; A Piacentini; S Toneguzzi; F Grassi; B Cocchini; A Ferruzzi; G Gualtieri; A Facchini
Journal:  Clin Exp Immunol       Date:  2000-02       Impact factor: 4.330

3.  Measurement of activity of collagenolytic MMP and inhibitors of MMPs using radiolabeled collagen substrate.

Authors:  Tim E Cawston
Journal:  Nat Protoc       Date:  2009-02-12       Impact factor: 13.491

4.  Interleukin 13 blocks the release of collagen from bovine nasal cartilage treated with proinflammatory cytokines.

Authors:  C S Cleaver; A D Rowan; T E Cawston
Journal:  Ann Rheum Dis       Date:  2001-02       Impact factor: 19.103

5.  Esculetin inhibits cartilage resorption induced by interleukin 1alpha in combination with oncostatin M.

Authors:  S Elliott; A D Rowan; S Carrère; P Koshy; J B Catterall; T E Cawston
Journal:  Ann Rheum Dis       Date:  2001-02       Impact factor: 19.103

6.  Effects of different omega-3 sources, fish oil, krill oil, and green-lipped mussel against cytokine-mediated canine cartilage degradation.

Authors:  Kittisak Buddhachat; Puntita Siengdee; Siriwadee Chomdej; Kumpanart Soontornvipart; Korakot Nganvongpanit
Journal:  In Vitro Cell Dev Biol Anim       Date:  2017-01-11       Impact factor: 2.416

7.  MicroRNA-9 promotion of interleukin-6 expression by inhibiting monocyte chemoattractant protein-induced protein 1 expression in interleukin-1β-stimulated human chondrocytes.

Authors:  Mohammad S Makki; Abdul Haseeb; Tariq M Haqqi
Journal:  Arthritis Rheumatol       Date:  2015-05       Impact factor: 10.995

8.  An exploration of the ability of tepoxalin to ameliorate the degradation of articular cartilage in a canine in vitro model.

Authors:  Lisa Macrory; Anne Vaughan-Thomas; Peter D Clegg; John F Innes
Journal:  BMC Vet Res       Date:  2009-07-22       Impact factor: 2.741

9.  Increased expression of matrix metalloproteinase-10, nerve growth factor and substance P in the painful degenerate intervertebral disc.

Authors:  Stephen M Richardson; Paul Doyle; Ben M Minogue; Kanna Gnanalingham; Judith A Hoyland
Journal:  Arthritis Res Ther       Date:  2009-08-20       Impact factor: 5.156

10.  Human rheumatoid arthritis tissue production of IL-17A drives matrix and cartilage degradation: synergy with tumour necrosis factor-alpha, Oncostatin M and response to biologic therapies.

Authors:  Ellen M Moran; Ronan Mullan; Jennifer McCormick; Mary Connolly; Owen Sullivan; Oliver Fitzgerald; Barry Bresnihan; Douglas J Veale; Ursula Fearon
Journal:  Arthritis Res Ther       Date:  2009-07-23       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.